| |SEPTEMBER 20248ORDI & ST JOHN'S MEDICAL COLLEGE TEAM UP TO SUPPORT KIDNEY DISEASE PATIENTSMAX HEALTHCARE ACQUIRES JAYPEE HEALTHCARE FOR 1,660 CROREThe Organisation for Rare illnesses India (ORDI) and St John's Medical College and Hospital have signed a Memorandum of Understanding (MoU) to help children with rare kidney diseases and their families. These include about 150 rare illnesses, which are typically associated with low prevalence and complex cause.These illnesses can have a significant influence on renal function and overall health. Despite their rarity, they have a global impact on millions of people. There are about 150 uncommon kidney illnesses documented, the majority of which are inherited.The Alliance for Rare Kidneys combines the expertise of St John's Paediatric Nephrology and ORDI to form the Rare Disease Care Coordination Centre (RDCCC) at SJMCH in Bengaluru. At the inaugural event of the Alliance for Rare KIDneys support group, Fr Jesudoss Rajamanickam, director, SJMCH, Rev. Tony AJ, associate director- finance, SJMCH, Dr. Tony D S Raj, Dean of St John`s Research Institute, Dr Priya Pais, Professor and Head, Department of Paediatric Nephrology Master Karthik & Likitha- patients, Prasanna Shirol, co-founder & executive director, ORDI were present at the at Unit of Hope, St John's Medical College Hospital. Dr Pais, said, "Our partnership with ORDI aims to improve the overall wellbeing of children suffering from rare and chronic kidney diseases. While we provide the highest level of medical care, we acknowledge that our patients and their families face many struggles, from the lack of availability of disease modifying drugs in India, the uncertainty of a lifelong disease and its burdens on the family to the challenges of integrating normal childhood activities like education and social relationships. POMax Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of the company's overall worth.According to the deal, Max Healthcare will help repay the debts owed to financial creditors of JHL and also plans to purchase a 64 percent share in the company, along with options to buy or sell the rest of the stake.Max Healthcare may secure a short term loan of up to ?1,000 crore from banks and financial institutions in order to finance the acquisition and refinance the current debt at JHL as a temporary solution.Max stated that the temporary financial support given to JHL by the company will be refunded when JHL receives its regular loan from banks or financial institutions after the acquisition."Addition of Jaypee Healthcare Ltd. to the network is an important milestone in our journey to build a formidable presence in NCR ­ a region which is not only home to 46 million people but also plays a pivotal role in shaping the Indian economy as an economic hub," said Abhay Soi, chairman and managing director, Max Healthcare."We remain focused on formulating a comprehensive strategy that addresses the demands of all stakeholders involved while prioritizing the delivery of quality healthcare services in a sustainable manner and potentially expand the flagship Noida facility to 1200 beds over next few years," Soi said. POTOP STORIES
< Page 7 | Page 9 >